Related references
Note: Only part of the references are listed.Artificial Intelligence Techniques for Automated Diagnosis of Neurological Disorders
U. Raghavendra et al.
EUROPEAN NEUROLOGY (2020)
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk
Josefa Girona et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts
Ari V. Ahola-Olli et al.
DIABETOLOGIA (2019)
A plasma metabolite panel as biomarkers for early primary breast cancer detection
Baowen Yuan et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study
Poul Erik H. Jensen et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Treatment of multiple sclerosis - success from bench to bedside
Mar Tintore et al.
NATURE REVIEWS NEUROLOGY (2019)
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis
Antoine M. Klauser et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis
Antoine M. Klauser et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Exosomal lipids for classifying early and late stage non-small cell lung cancer
Teresa W. M. Fan et al.
ANALYTICA CHIMICA ACTA (2018)
Alemtuzumab depletion failure can occur in multiple sclerosis
Nicolas Dubuisson et al.
IMMUNOLOGY (2018)
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy
Joern Loetsch et al.
SCIENTIFIC REPORTS (2018)
Structural neuroimaging as clinical predictor: A review of machine learning applications
Jose Maria Mateos-Perez et al.
NEUROIMAGE-CLINICAL (2018)
Cholesterol level correlate with disability score in patients with relapsing-remitting form of multiple sclerosis
M. Durfinova et al.
NEUROSCIENCE LETTERS (2018)
Lipoprotein markers associated with disability from multiple sclerosis
A. R. Gafson et al.
SCIENTIFIC REPORTS (2018)
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients
Marsilio Adriani et al.
JCI INSIGHT (2018)
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients
Tomas Uher et al.
JOURNAL OF LIPID RESEARCH (2017)
Evolving concepts in the treatment of relapsing multiple sclerosis
Giancarlo Comi et al.
LANCET (2017)
Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta
Kathleen Ingenhoven et al.
FRONTIERS IN NEUROLOGY (2017)
Exploration of machine learning techniques in predicting multiple sclerosis disease course
Yijun Zhao et al.
PLOS ONE (2017)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies
Peter Wurtz et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
Evaluation of Classifier Performance for Multiclass Phenotype Discrimination in Untargeted Metabolomics
Patrick J. Trainor et al.
METABOLITES (2017)
An interaction map of circulating metabolites, immune gene networks, and their genetic regulation
Artika P. Nath et al.
GENOME BIOLOGY (2017)
Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease
Ayaka Ito et al.
IMMUNITY (2016)
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta
Christina Hermanrud et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis
Delphine Bachelet et al.
PLOS ONE (2016)
Introduction to machine learning: k-nearest neighbors
Zhongheng Zhang
ANNALS OF TRANSLATIONAL MEDICINE (2016)
1H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
Eleonora Cocco et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque
Edward Smith et al.
SCIENCE IMMUNOLOGY (2016)
A Conserved Circular Network of Coregulated Lipids Modulates Innate Immune Responses
Marielle S. Koeberlin et al.
CELL (2015)
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Gorm Pihl-Jensen et al.
CNS DRUGS (2015)
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis
C. van de Kraats et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
Alex M. Dickens et al.
NEUROLOGY (2014)
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
Christian P. Kamm et al.
PLOS ONE (2014)
Immunoglobulin G1 and immunoglobulin G4 antibodies in multiple sclerosis patients treated with IFNβ interact with the endogenous cytokine and activate complement
Swaminathan Sethu et al.
CLINICAL IMMUNOLOGY (2013)
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
Anke Vennegoor et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
FATAL NEUROINFLAMMATION IN A CASE OF MULTIPLE SCLEROSIS WITH ANTI-NATALIZUMAB ANTIBODIES
Anders Svenningsson et al.
NEUROLOGY (2013)
High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function
Mary G. Sorci-Thomas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients
F. Weber et al.
PHARMACOGENOMICS JOURNAL (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Primary Human CD4+ T Cells Have Diverse Levels of Membrane Lipid Order That Correlate with Their Function
Laura Miguel et al.
JOURNAL OF IMMUNOLOGY (2011)
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes
Wei Yu et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2010)
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
Chris H. Polman et al.
LANCET NEUROLOGY (2010)
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism
Pasi Soininen et al.
ANALYST (2009)
Absence of MxA induction by interferon β in patients with MS reflects complete loss of bioactivity
D. Hesse et al.
NEUROLOGY (2009)
HLA-DRBI*0401 and HLA-DRBI*0408 are strongly associated with the development of antibodies against interferon-β therapy in multiple sclerosis
Steve Hoffmann et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Analysis of metabolomic data using support vector machines
Sankar Mahadevan et al.
ANALYTICAL CHEMISTRY (2008)
Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages
Xuewei Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
A. Sominanda et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
What are decision trees?
Carl Kingsford et al.
NATURE BIOTECHNOLOGY (2008)
Random forests for classification in ecology
D. Richard Cutler et al.
ECOLOGY (2007)
Are ex vivo neutralising antibodies against IFN-β always detrimental to therapeutic efficacy in multiple sclerosis?
P. S. Sorensen et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Neutralizing antibodies and efficacy of interferon β-1a -: A 4-year controlled study
L Kappos et al.
NEUROLOGY (2005)
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
PS Sorensen et al.
LANCET (2003)
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory
A Bertolotto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
JW Skeggs et al.
JOURNAL OF LIPID RESEARCH (2002)
Share Paper
